KCNJ11 and diabetes mellitus: The ongoing detection of the commonest subtype of neonatal diabetes due to KCNJ11/ABCC8 mutations who can be transferred to inexpensive sulfonylurea treatment makes testing all those below 12 months still cost-saving, so long as 3% of those screened have a monogenic diabetes diagnosis that is treatment-changing8.